Catalog Number | Description | For Use With (Application) | Form |
---|---|---|---|
081693N | Diluent for B·R·A·H·M·S AFP KRYPTOR | Dilution of samples for AFP measurement on B·R·A·H·M·S KRYPTOR compact PLUS/KRYPTOR GOLD | Ready-to-Use (RTU) |
816075N | Immunofluorescent assay for quantitative determination of Alpha-Fetoprotein (AFP) | Aid in risk assessment of fetal trisomy 21 in first trimester of pregnancy, risk assessment of fetal trisomy 21 and 18 in second trimester of pregnancy, an aid to be used in conjunction with clinical evaluation for non-invasive risk assessment of fetal neural tube defects in serum and plasma (herapin) and diagnosis of fetal neural tube defects in amniotic fluid in the second trimester in pregnant women, aid in diagnosis of patients with suspected hepatocellular carcinomas or non-seminomatous germ cell tumors, and in the follow up of patients with confirmed hepatocellular carcinomas or non-seminomatous germ cell tumors. | Lyophilized |
081691N | Calibrator for B·R·A·H·M·S AFP KRYPTOR (1 level) | Readjust the standard curve memorized in B·R·A·H·M·S KRYPTOR compact PLUS/KRYPTOR GOLD | Ready-to-Use (RTU) |
B·R·A·H·M·S provides a complete portfolio of biomarkers for the screening of fetal defects in first and second trimester of pregnancy and biomarkers for diagnosis and monitoring of cancer. B·R·A·H·M·S AFP KRYPTOR is indicated as an aid to be used in conjunction with clinical evaluation to help identify pregnancies at risk of trisomy 21 in first trimester, of trisomy 21 and 18 and neural tube defects in second trimester, and as an aid for the diagnosis and monitoring of patients with hepatocellular carcinomas or non-seminomatous germ cell tumors.
US Only: Product is not 510k cleared in US.
Get confidence in your results with the high precision of B·R·A·H·M·S AFP KRYPTOR and its short incubation time.